213 related articles for article (PubMed ID: 11066049)
1. Prostatourethral-rectal fistula after prostate brachytherapy.
Theodorescu D; Gillenwater JY; Koutrouvelis PG
Cancer; 2000 Nov; 89(10):2085-91. PubMed ID: 11066049
[TBL] [Abstract][Full Text] [Related]
2. Recto-urethral fistula following brachytherapy for localized prostate cancer.
Shakespeare D; Mitchell DM; Carey BM; Finan P; Henry AM; Ash D; Bottomley DM; Al-Qaisieh B
Colorectal Dis; 2007 May; 9(4):328-31. PubMed ID: 17432984
[TBL] [Abstract][Full Text] [Related]
3. Rectourethral fistula after combination radiotherapy for prostate cancer.
Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
[TBL] [Abstract][Full Text] [Related]
4. Rectal complications after prostate brachytherapy.
Shah SA; Cima RR; Benoit E; Breen EL; Bleday R
Dis Colon Rectum; 2004 Sep; 47(9):1487-92. PubMed ID: 15486745
[TBL] [Abstract][Full Text] [Related]
5. Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer.
Ecke TH; Huang-Tiel HJ; Golka K; Selinski S; Geis BC; Koswig S; Bathe K; Hallmann S; Gerullis H
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834929
[TBL] [Abstract][Full Text] [Related]
6. Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report.
Cherr GS; Hall C; Pineau BC; Waters GS
Am Surg; 2001 Feb; 67(2):131-4. PubMed ID: 11243535
[TBL] [Abstract][Full Text] [Related]
7. Rectal bleeding after high-dose-rate brachytherapy combined with hypofractionated external-beam radiotherapy for localized prostate cancer: the relationship between dose-volume histogram parameters and the occurrence rate.
Okamoto M; Ishikawa H; Ebara T; Kato H; Tamaki T; Akimoto T; Ito K; Miyakubo M; Yamamoto T; Suzuki K; Takahashi T; Nakano T
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e211-7. PubMed ID: 21620579
[TBL] [Abstract][Full Text] [Related]
8. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
9. Management of radiotherapy induced rectourethral fistula.
Lane BR; Stein DE; Remzi FH; Strong SA; Fazio VW; Angermeier KW
J Urol; 2006 Apr; 175(4):1382-7; discussion 1387-8. PubMed ID: 16516003
[TBL] [Abstract][Full Text] [Related]
10. Rectal fistulae after salvage high-intensity focused ultrasound for recurrent prostate cancer after combined brachytherapy and external beam radiotherapy.
Ahmed HU; Ishaq A; Zacharakis E; Shaw G; Illing R; Allen C; Kirkham A; Emberton M
BJU Int; 2009 Feb; 103(3):321-3. PubMed ID: 19021611
[TBL] [Abstract][Full Text] [Related]
11. Predictive factors of long-term rectal toxicity following permanent iodine-125 prostate brachytherapy with or without supplemental external beam radiation therapy in 2216 patients.
Tanaka T; Yorozu A; Sutani S; Yagi Y; Nishiyama T; Shiraishi Y; Ohashi T; Hanada T; Saito S; Toya K; Shigematsu N
Brachytherapy; 2018; 17(5):799-807. PubMed ID: 29936128
[TBL] [Abstract][Full Text] [Related]
12. Rectal Ulcers and Rectoprostatic Fistulas after (125)I Low Dose Rate Prostate Brachytherapy.
Leong N; Pai HH; Morris WJ; Keyes M; Pickles T; Tyldesley S; Wu J;
J Urol; 2016 Jun; 195(6):1811-6. PubMed ID: 26778712
[TBL] [Abstract][Full Text] [Related]
13. Brachytherapy improves biochemical failure-free survival in low- and intermediate-risk prostate cancer compared with conventionally fractionated external beam radiation therapy: a propensity score matched analysis.
Smith GD; Pickles T; Crook J; Martin AG; Vigneault E; Cury FL; Morris J; Catton C; Lukka H; Warner A; Yang Y; Rodrigues G
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):505-16. PubMed ID: 25596107
[TBL] [Abstract][Full Text] [Related]
14. Devastating complications after brachytherapy in the treatment of prostate adenocarcinoma.
Moreira SG; Seigne JD; Ordorica RC; Marcet J; Pow-Sang JM; Lockhart JL
BJU Int; 2004 Jan; 93(1):31-5. PubMed ID: 14678363
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.
Fang FM; Wang YM; Wang CJ; Huang HY; Chiang PH
Jpn J Clin Oncol; 2008 Jul; 38(7):474-9. PubMed ID: 18621848
[TBL] [Abstract][Full Text] [Related]
16. 3D conformal HDR brachytherapy and external beam irradiation combined with temporary androgen deprivation in the treatment of localized prostate cancer.
Martin T; Röddiger S; Kurek R; Dannenberg T; Eckart O; Kolotas C; Heyd R; Rogge B; Baltas D; Tunn U; Zamboglou N
Radiother Oncol; 2004 Apr; 71(1):35-41. PubMed ID: 15066294
[TBL] [Abstract][Full Text] [Related]
17. Posterior urethral complications of the treatment of prostate cancer.
Mundy AR; Andrich DE
BJU Int; 2012 Aug; 110(3):304-25. PubMed ID: 22340079
[TBL] [Abstract][Full Text] [Related]
18. Recto-urethral fistula following brachytherapy for localized prostate cancer.
Jongen J; Braun PM; Jünemann KP
Colorectal Dis; 2008 Jun; 10(5):522; author reply 522. PubMed ID: 18400038
[No Abstract] [Full Text] [Related]
19. Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer.
Freiberger C; Berneking V; Vögeli TA; Kirschner-Hermanns R; Eble MJ; Pinkawa M
Brachytherapy; 2018; 17(3):517-523. PubMed ID: 29496423
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
